SCHEMBL4592987

SCHEMBL4592987

O=C=Nc1ccc(OC(F)(F)F)cc1I

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 5/20 0.38
CYP3A4 P08684 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
HPGD P15428 1/20 0.36
CES1 P23141 1/20 0.36
MAPT P10636 2/20 0.33
TRPV1 Q8NER1 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
KIF11 P52732 1/20 0.33
EPHX2 P34913 1/20 0.33
PIM1 P11309 1/20 0.33
PDE2A O00408 1/20 0.32
TP53 P04637 2/20 0.32
ALOX15 P16050 2/20 0.32
BLM P54132 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9826837 0.81 CYP3A4 (0.41) GPR3CYP3A4ALDH1A1TDP1HPGD
SCHEMBL11339200 0.81 GPR3 (0.38) GPR3CYP3A4ALDH1A1TDP1HPGD
SCHEMBL30076337 0.76 MEN1 (0.38) GPR3CYP3A4ALDH1A1TDP1HPGD
SCHEMBL19135997 0.76 MEN1 (0.38) GPR3CYP3A4ALDH1A1TDP1HPGD
SCHEMBL22714098 0.73 GPR3 (0.48) GPR3CYP3A4CES1MAPTTRPV1
SCHEMBL24246067 0.72 MAPK1 (0.41) GPR3CYP3A4TDP1CES1KDM4E
SCHEMBL22573124 0.72 MAPK1 (0.34) TDP1MAPK1
SCHEMBL20798330 0.72 CYP3A4 (0.38) CYP3A4ALDH1A1TDP1HPGDMAPK1
SCHEMBL180952 0.72 TSHR (0.45) GPR3CYP3A4ALDH1A1TDP1MAPT
SCHEMBL6411536 0.72 GPR3 (0.44) GPR3CYP3A4CES1MAPTTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004607-A2 NEW COMPOUNDS Novartis AG (CH) 2008-12-24 EP disclosed
EP-1896412-A2 OXINDOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-03-12 EP disclosed
WO-2007126957-A2 NEW COMPOUNDS NOVARTIS AG (CH) 2007-11-08 WO disclosed
WO-2006136606-A2 OXINDOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-12-28 WO disclosed